Research article · 27 Jul 2026
Conference abstractPublished 30 Jan 2017
Pre-exposure prophylaxis (PrEP) accessibility research and evaluation 2 (PrEPARE 2): HIV risk perception among men who have sex with men (MSM)
University of California, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Despite greater access to PrEP, a barrier to HIV prevention is inaccurate risk perception by MSM. PrEPARE2 is a randomized controlled trial to determine if providing at-risk HIV-uninfected MSM with a calculated risk score affects PrEP uptake. Objective: Our objective is to compare self-perceived risk (SPR) to an objective HIV risk score (UCSD score). Methods: HIV-uninfected, at-risk MSM were recruited from San Diego testing sites. At-risk for HIV can be defined as having one or more episodes of insertive or receptive condomless anal intercourse (CAI) with a HIV-infected partner or partner of unknown status within 6 months. Enrolled subjects received an iPad survey to assess baseline characteristics including demographics and risk behaviors. SPR score was the subjectâÂ?Â?s perceived likelihood of becoming HIV-infected. The survey also generates the UCSD score, which calculates an individualâÂ?Â?s risk of becoming infected over one year and places individuals into risk categories, calculated from event frequencies of UAI, history of sexually transmitted infections and shared needle events. SPR and UCSD score categories include low, medium, high and very high. CohenâÂ?Â?s kappa coefficient evaluated the agreement between the two measures. Results: Of 78 participants enrolled, median age was 32, 31% identified as Latino, 67% as white, 13% as black. Most subjects had heard of PrEP (78%), and 53% thought they were good candidates for it. Overall, the group had a median of 5 sexual partners in the last 6 months (IQR: 3-10) and 72% had at least one receptive CAI within the past 6 months. The SPR had poor agreement with the objective score (kappa=0.009). Most subjects (55%) underestimated their HIV risk, 36% had concordant predictions, and 9% overestimated their risk. 15 of 16 subjects with a high UCSD score underestimated their risk. Underestimation of risk was not associated with any demographic or risk factors, including number of sex partners and drug use. Conclusions: In this sample of HIV-negative MSM, there was high discordance between self-perceived and actual HIV risk and a tendency to underestimate risk, particularly in high-risk individuals. Greater emphasis on objective HIV risk may be an important component of successful PrEP uptake.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Evan Mulvihill”
- BylineArticles whose byline prints “Sonia Jain”
- BylineArticles whose byline prints “Shelly Sun”
- BylineArticles whose byline prints “Marvin Hanashiro”
- BylineArticles whose byline prints “Sheldon Morris”
- BylineArticles whose byline prints “Jill Blumenthal”